APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticle (LNP) Formulation

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lipid Nanoparticle (LNP) Formulation Market Analysis and Forecast 2026-2032

5 June 2026189 pages

Choose your research edition.

Industry ResearchLipid Nanoparticle (LNP) Formulation Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticle (LNP) Formulation Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticle (LNP) Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticle (LNP) Formulation Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticle (LNP) Formulation Market Analysis and Forecast 2026-2032189 pages · $4,950 USD

Market perspective

The global Lipid Nanoparticle (LNP) Formulation market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Lipid Nanoparticle (LNP) Formulation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lipid Nanoparticle (LNP) Formulation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lipid Nanoparticle (LNP) Formulation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lipid Nanoparticle (LNP) Formulation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Lipid Nanoparticle (LNP) Formulation include Precision NanoSystems (Cytiva), Ascendia Pharmaceuticals, CordenPharma, Evonik, Merck Millipore, Esco Aster, WuXi STA and Helix Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Lipid Nanoparticle (LNP) Formulation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lipid Nanoparticle (LNP) Formulation, also provides the revenue of main regions and countries. Of the upcoming market potential for Lipid Nanoparticle (LNP) Formulation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lipid Nanoparticle (LNP) Formulation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lipid Nanoparticle (LNP) Formulation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Lipid Nanoparticle (LNP) Formulation revenue, projected growth trends, production technology, application and end-user industry.

Lipid Nanoparticle (LNP) Formulation Segment by Company

Precision NanoSystems (Cytiva)

Ascendia Pharmaceuticals

CordenPharma

Evonik

Merck Millipore

Esco Aster

WuXi STA

Helix Biotech

Lipid Nanoparticle (LNP) Formulation Segment by Type

mRNA-lipid Nanoparticle

siRNA-lipid Nanoparticle

Lipid Nanoparticle (LNP) Formulation Segment by Application

In Vitro and In Vivo Diagnostics

Medical Imaging

Nanotherapeutics

Vaccines

Regenerative Medicine

Lipid Nanoparticle (LNP) Formulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle (LNP) Formulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle (LNP) Formulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle (LNP) Formulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Lipid Nanoparticle (LNP) Formulation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Lipid Nanoparticle (LNP) Formulation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Nanoparticle (LNP) Formulation revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. mRNA-lipid Nanoparticle Major Player Table 3. siRNA-lipid Nanoparticle Major Player Table 4. Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. In Vitro and In Vivo Diagnostics Major Player Table 6. Medical Imaging Major Player Table 7. Nanotherapeutics Major Player Table 8. Vaccines Major Player Table 9. Regenerative Medicine Major Player Table 10. Lipid Nanoparticle (LNP) Formulation Industry Trends Table 11. Lipid Nanoparticle (LNP) Formulation Industry Drivers Table 12. Lipid Nanoparticle (LNP) Formulation Industry Opportunities and Challenges Table 13. Lipid Nanoparticle (LNP) Formulation Industry Restraints Table 14. Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Lipid Nanoparticle (LNP) Formulation Market Share by Region (2021-2026) Table 17. Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Lipid Nanoparticle (LNP) Formulation Market Share by Region (2027-2032) Table 19. Global Lipid Nanoparticle (LNP) Formulation Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Players (2021-2026) Table 21. Global Lipid Nanoparticle (LNP) Formulation Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Lipid Nanoparticle (LNP) Formulation Key Players Headquarters & Area Served Table 23. Global Lipid Nanoparticle (LNP) Formulation Players, Product Type & Application Table 24. Global Lipid Nanoparticle (LNP) Formulation Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Lipid Nanoparticle (LNP) Formulation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Lipid Nanoparticle (LNP) Formulation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Type (2021-2026) Table 31. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Type (2027-2032) Table 32. Global Lipid Nanoparticle (LNP) Formulation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Application (2021-2026) Table 36. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Application (2027-2032) Table 37. Precision NanoSystems (Cytiva) Company Information Table 38. Precision NanoSystems (Cytiva) Business Overview Table 39. Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 41. Precision NanoSystems (Cytiva) Recent Development Table 42. Ascendia Pharmaceuticals Company Information Table 43. Ascendia Pharmaceuticals Business Overview Table 44. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 46. Ascendia Pharmaceuticals Recent Development Table 47. CordenPharma Company Information Table 48. CordenPharma Business Overview Table 49. CordenPharma Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. CordenPharma Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 51. CordenPharma Recent Development Table 52. Evonik Company Information Table 53. Evonik Business Overview Table 54. Evonik Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Evonik Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 56. Evonik Recent Development Table 57. Merck Millipore Company Information Table 58. Merck Millipore Business Overview Table 59. Merck Millipore Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Merck Millipore Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 61. Merck Millipore Recent Development Table 62. Esco Aster Company Information Table 63. Esco Aster Business Overview Table 64. Esco Aster Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Esco Aster Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 66. Esco Aster Recent Development Table 67. WuXi STA Company Information Table 68. WuXi STA Business Overview Table 69. WuXi STA Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. WuXi STA Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 71. WuXi STA Recent Development Table 72. Helix Biotech Company Information Table 73. Helix Biotech Business Overview Table 74. Helix Biotech Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Helix Biotech Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 76. Helix Biotech Recent Development Table 77. North America Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026) & (US$ Million) Table 80. North America Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032) & (US$ Million) Table 81. North America Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021-2026) & (US$ Million) Table 83. North America Lipid Nanoparticle (LNP) Formulation Revenue by Country (US$ Million) & (2027-2032) Table 84. Europe Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026) & (US$ Million) Table 87. Europe Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032) & (US$ Million) Table 88. Europe Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Europe Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021-2026) & (US$ Million) Table 90. Europe Lipid Nanoparticle (LNP) Formulation Revenue by Country (US$ Million) & (2027-2032) Table 91. China Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026) & (US$ Million) Table 92. China Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032) & (US$ Million) Table 93. China Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026) & (US$ Million) Table 94. China Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032) & (US$ Million) Table 95. Asia Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026) & (US$ Million) Table 96. Asia Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032) & (US$ Million) Table 97. Asia Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026) & (US$ Million) Table 98. Asia Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032) & (US$ Million) Table 99. Asia Lipid Nanoparticle (LNP) Formulation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Asia Lipid Nanoparticle (LNP) Formulation Revenue by Region (US$ Million) & (2021-2026) Table 101. Asia Lipid Nanoparticle (LNP) Formulation Revenue by Region (US$ Million) & (2027-2032) Table 102. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026) & (US$ Million) Table 103. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032) & (US$ Million) Table 104. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026) & (US$ Million) Table 105. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032) & (US$ Million) Table 106. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021-2026) & (US$ Million) Table 108. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Country (US$ Million) & (2027-2032) Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Lipid Nanoparticle (LNP) Formulation Image Figure 2. Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lipid Nanoparticle (LNP) Formulation Market Size Share 2021 VS 2025 VS 2032 Figure 4. mRNA-lipid Nanoparticle Image Figure 5. siRNA-lipid Nanoparticle Image Figure 6. Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Lipid Nanoparticle (LNP) Formulation Market Size Share 2021 VS 2025 VS 2032 Figure 8. In Vitro and In Vivo Diagnostics Image Figure 9. Medical Imaging Image Figure 10. Nanotherapeutics Image Figure 11. Vaccines Image Figure 12. Regenerative Medicine Image Figure 13. Global Lipid Nanoparticle (LNP) Formulation Market Size (US$ Million) & (2021-2032) Figure 14. Global Lipid Nanoparticle (LNP) Formulation Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Lipid Nanoparticle (LNP) Formulation Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Lipid Nanoparticle (LNP) Formulation Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Type (2021-2032) Figure 21. Global Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Application (2021-2032) Figure 24. North America Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Lipid Nanoparticle (LNP) Formulation Revenue Share by Type (2021-2032) Figure 26. North America Lipid Nanoparticle (LNP) Formulation Revenue Share by Application (2021-2032) Figure 27. North America Lipid Nanoparticle (LNP) Formulation Revenue Share by Country (2021-2032) Figure 28. United States Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Lipid Nanoparticle (LNP) Formulation Revenue Share by Type (2021-2032) Figure 33. Europe Lipid Nanoparticle (LNP) Formulation Revenue Share by Application (2021-2032) Figure 34. Europe Lipid Nanoparticle (LNP) Formulation Revenue Share by Country (2021-2032) Figure 35. Germany Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Lipid Nanoparticle (LNP) Formulation Revenue Share by Type (2021-2032) Figure 45. China Lipid Nanoparticle (LNP) Formulation Revenue Share by Application (2021-2032) Figure 46. Asia Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Lipid Nanoparticle (LNP) Formulation Revenue Share by Type (2021-2032) Figure 48. Asia Lipid Nanoparticle (LNP) Formulation Revenue Share by Application (2021-2032) Figure 49. Asia Lipid Nanoparticle (LNP) Formulation Revenue Share by Region (2021-2032) Figure 50. Japan Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue Share by Type (2021-2032) Figure 58. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue Share by Application (2021-2032) Figure 59. SAMEA Lipid Nanoparticle (LNP) Formulation Revenue Share by Country (2021-2032) Figure 60. Brazil Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Lipid Nanoparticle (LNP) Formulation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • mRNA-lipid Nanoparticle
  • siRNA-lipid Nanoparticle
Applications
  • In Vitro and In Vivo Diagnostics
  • Medical Imaging
  • Nanotherapeutics
  • Vaccines
  • Regenerative Medicine
Companies covered
  • Precision NanoSystems (Cytiva)
  • Ascendia Pharmaceuticals
  • CordenPharma
  • Evonik
  • Merck Millipore
  • Esco Aster
  • WuXi STA
  • Helix Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lipid Nanoparticle (LNP) Formulation Market by Type
  3. 1.2.1 Global Lipid Nanoparticle (LNP) Formulation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 mRNA-lipid Nanoparticle
  5. 1.2.3 siRNA-lipid Nanoparticle
  6. 1.3 Lipid Nanoparticle (LNP) Formulation Market by Application
  7. 1.3.1 Global Lipid Nanoparticle (LNP) Formulation Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 In Vitro and In Vivo Diagnostics
  9. 1.3.3 Medical Imaging
  10. 1.3.4 Nanotherapeutics
  11. 1.3.5 Vaccines
  12. 1.3.6 Regenerative Medicine
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Lipid Nanoparticle (LNP) Formulation Market Dynamics
  1. 2.1 Lipid Nanoparticle (LNP) Formulation Industry Trends
  2. 2.2 Lipid Nanoparticle (LNP) Formulation Industry Drivers
  3. 2.3 Lipid Nanoparticle (LNP) Formulation Industry Opportunities and Challenges
  4. 2.4 Lipid Nanoparticle (LNP) Formulation Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Lipid Nanoparticle (LNP) Formulation Market Perspective (2021-2032)
  2. 3.2 Global Lipid Nanoparticle (LNP) Formulation Growth Trends by Region
  3. 3.2.1 Global Lipid Nanoparticle (LNP) Formulation Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2021-2026)
  5. 3.2.3 Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Lipid Nanoparticle (LNP) Formulation Revenue by Players
  2. 4.1.1 Global Lipid Nanoparticle (LNP) Formulation Revenue by Players (2021-2026)
  3. 4.1.2 Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Lipid Nanoparticle (LNP) Formulation Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lipid Nanoparticle (LNP) Formulation Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Lipid Nanoparticle (LNP) Formulation Key Players Headquarters & Area Served
  7. 4.4 Global Lipid Nanoparticle (LNP) Formulation Players, Product Type & Application
  8. 4.5 Global Lipid Nanoparticle (LNP) Formulation Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Lipid Nanoparticle (LNP) Formulation Market CR5 and HHI
  11. 4.6.3 2025 Lipid Nanoparticle (LNP) Formulation Tier 1, Tier 2, and Tier 3
5 Lipid Nanoparticle (LNP) Formulation Market Size by Type
  1. 5.1 Global Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2032)
  3. 5.3 Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Type (2021-2032)
6 Lipid Nanoparticle (LNP) Formulation Market Size by Application
  1. 6.1 Global Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2032)
  3. 6.3 Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Precision NanoSystems (Cytiva)
  2. 7.1.1 Precision NanoSystems (Cytiva) Company Information
  3. 7.1.2 Precision NanoSystems (Cytiva) Business Overview
  4. 7.1.3 Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Product Portfolio
  6. 7.1.5 Precision NanoSystems (Cytiva) Recent Developments
  7. 7.2 Ascendia Pharmaceuticals
  8. 7.2.1 Ascendia Pharmaceuticals Company Information
  9. 7.2.2 Ascendia Pharmaceuticals Business Overview
  10. 7.2.3 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Product Portfolio
  12. 7.2.5 Ascendia Pharmaceuticals Recent Developments
  13. 7.3 CordenPharma
  14. 7.3.1 CordenPharma Company Information
  15. 7.3.2 CordenPharma Business Overview
  16. 7.3.3 CordenPharma Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (2021-2026)
  17. 7.3.4 CordenPharma Lipid Nanoparticle (LNP) Formulation Product Portfolio
  18. 7.3.5 CordenPharma Recent Developments
  19. 7.4 Evonik
  20. 7.4.1 Evonik Company Information
  21. 7.4.2 Evonik Business Overview
  22. 7.4.3 Evonik Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Evonik Lipid Nanoparticle (LNP) Formulation Product Portfolio
  24. 7.4.5 Evonik Recent Developments
  25. 7.5 Merck Millipore
  26. 7.5.1 Merck Millipore Company Information
  27. 7.5.2 Merck Millipore Business Overview
  28. 7.5.3 Merck Millipore Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Merck Millipore Lipid Nanoparticle (LNP) Formulation Product Portfolio
  30. 7.5.5 Merck Millipore Recent Developments
  31. 7.6 Esco Aster
  32. 7.6.1 Esco Aster Company Information
  33. 7.6.2 Esco Aster Business Overview
  34. 7.6.3 Esco Aster Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Esco Aster Lipid Nanoparticle (LNP) Formulation Product Portfolio
  36. 7.6.5 Esco Aster Recent Developments
  37. 7.7 WuXi STA
  38. 7.7.1 WuXi STA Company Information
  39. 7.7.2 WuXi STA Business Overview
  40. 7.7.3 WuXi STA Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (2021-2026)
  41. 7.7.4 WuXi STA Lipid Nanoparticle (LNP) Formulation Product Portfolio
  42. 7.7.5 WuXi STA Recent Developments
  43. 7.8 Helix Biotech
  44. 7.8.1 Helix Biotech Company Information
  45. 7.8.2 Helix Biotech Business Overview
  46. 7.8.3 Helix Biotech Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Helix Biotech Lipid Nanoparticle (LNP) Formulation Product Portfolio
  48. 7.8.5 Helix Biotech Recent Developments
8 North America
  1. 8.1 North America Lipid Nanoparticle (LNP) Formulation Revenue (2021-2032)
  2. 8.2 North America Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2032)
  3. 8.2.1 North America Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026)
  4. 8.2.2 North America Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032)
  5. 8.3 North America Lipid Nanoparticle (LNP) Formulation Revenue Share by Type (2021-2032)
  6. 8.4 North America Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2032)
  7. 8.4.1 North America Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026)
  8. 8.4.2 North America Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032)
  9. 8.5 North America Lipid Nanoparticle (LNP) Formulation Revenue Share by Application (2021-2032)
  10. 8.6 North America Lipid Nanoparticle (LNP) Formulation Revenue by Country
  11. 8.6.1 North America Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021-2026)
  13. 8.6.3 North America Lipid Nanoparticle (LNP) Formulation Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Lipid Nanoparticle (LNP) Formulation Revenue (2021-2032)
  2. 9.2 Europe Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2032)
  3. 9.2.1 Europe Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026)
  4. 9.2.2 Europe Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032)
  5. 9.3 Europe Lipid Nanoparticle (LNP) Formulation Revenue Share by Type (2021-2032)
  6. 9.4 Europe Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2032)
  7. 9.4.1 Europe Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026)
  8. 9.4.2 Europe Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032)
  9. 9.5 Europe Lipid Nanoparticle (LNP) Formulation Revenue Share by Application (2021-2032)
  10. 9.6 Europe Lipid Nanoparticle (LNP) Formulation Revenue by Country
  11. 9.6.1 Europe Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021-2026)
  13. 9.6.3 Europe Lipid Nanoparticle (LNP) Formulation Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Lipid Nanoparticle (LNP) Formulation Revenue (2021-2032)
  2. 10.2 China Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2032)
  3. 10.2.1 China Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026)
  4. 10.2.2 China Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032)
  5. 10.3 China Lipid Nanoparticle (LNP) Formulation Revenue Share by Type (2021-2032)
  6. 10.4 China Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2032)
  7. 10.4.1 China Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026)
  8. 10.4.2 China Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032)
  9. 10.5 China Lipid Nanoparticle (LNP) Formulation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lipid Nanoparticle (LNP) Formulation Revenue (2021-2032)
  2. 11.2 Asia Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2032)
  3. 11.2.1 Asia Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026)
  4. 11.2.2 Asia Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032)
  5. 11.3 Asia Lipid Nanoparticle (LNP) Formulation Revenue Share by Type (2021-2032)
  6. 11.4 Asia Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2032)
  7. 11.4.1 Asia Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026)
  8. 11.4.2 Asia Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032)
  9. 11.5 Asia Lipid Nanoparticle (LNP) Formulation Revenue Share by Application (2021-2032)
  10. 11.6 Asia Lipid Nanoparticle (LNP) Formulation Revenue by Country
  11. 11.6.1 Asia Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021-2026)
  13. 11.6.3 Asia Lipid Nanoparticle (LNP) Formulation Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue (2021-2032)
  2. 12.2 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Type (2027-2032)
  5. 12.3 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Application (2027-2032)
  9. 12.5 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Country
  11. 12.6.1 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Lipid Nanoparticle (LNP) Formulation Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst